- Home
- CHPT vs XOMA Comparison
CHPT vs XOMA Comparison
Compare CHPT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- XOMA
- Stock Information
- Founded
- CHPT 2007
- XOMA 1981
- Country
- CHPT United States
- XOMA United States
- Employees
- CHPT N/A
- XOMA N/A
- Industry
- CHPT Industrial Specialties
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- CHPT Consumer Discretionary
- XOMA Health Care
- Exchange
- CHPT Nasdaq
- XOMA Nasdaq
- Market Cap
- CHPT 340.1M
- XOMA 330.2M
- IPO Year
- CHPT N/A
- XOMA N/A
- Fundamental
- Price
- CHPT $11.29
- XOMA $32.47
- Analyst Decision
- CHPT Hold
- XOMA Strong Buy
- Analyst Count
- CHPT 10
- XOMA 2
- Target Price
- CHPT $29.13
- XOMA $69.50
- AVG Volume (30 Days)
- CHPT 532.9K
- XOMA 57.0K
- Earning Date
- CHPT 09-03-2025
- XOMA 08-13-2025
- Dividend Yield
- CHPT N/A
- XOMA N/A
- EPS Growth
- CHPT N/A
- XOMA N/A
- EPS
- CHPT N/A
- XOMA N/A
- Revenue
- CHPT $407,681,000.00
- XOMA $44,952,000.00
- Revenue This Year
- CHPT $2.79
- XOMA $82.30
- Revenue Next Year
- CHPT $24.20
- XOMA $12.59
- P/E Ratio
- CHPT N/A
- XOMA N/A
- Revenue Growth
- CHPT N/A
- XOMA 194.98
- 52 Week Low
- CHPT $8.55
- XOMA $18.35
- 52 Week High
- CHPT $39.20
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- CHPT 47.09
- XOMA 61.79
- Support Level
- CHPT $11.41
- XOMA $32.60
- Resistance Level
- CHPT $11.85
- XOMA $34.60
- Average True Range (ATR)
- CHPT 0.59
- XOMA 1.82
- MACD
- CHPT 0.08
- XOMA 0.09
- Stochastic Oscillator
- CHPT 39.55
- XOMA 66.75
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.